PDF(Pubmed)
Abstract：
The potential adverse effects of coronavirus disease 2019 (COVID-19) vaccinations raise public concerns. Data from Taiwan\'s Vaccine Injury Compensation Program (VICP) can provide valuable insights. This study analyzed the preliminary application data for COVID-19 vaccine compensation in Taiwan\'s VICP, focusing on applicants receiving vaccines between March 2021 and June 2022. Among the 2941 adverse events, 113 cases (3.8%) were deemed causally associated with vaccination, 313 (10.6%) were indeterminate, and 2515 (85.5%) had no causal association. Nearly half (47.6%) of the applicants were over 60 years old, and 76.6% had a history of pre-existing chronic diseases. Among the 426 vaccine-associated or indeterminate cases, the most common causes were hematological diseases and thrombosis. There were 920 mortality cases reported, and 97.4% were unassociated with vaccination. Only five deaths were judged to be associated with the COVID-19 vaccination, all involving the adenovirus vector vaccine and thrombosis with thrombocytopenia syndrome. In conclusion, most compensation applications were not causally linked to vaccination. Compared to other countries, the number of applications in Taiwan\'s VICP is relatively high. These findings may indicate a need to adjust the application requirements for compensation in Taiwan\'s program.
摘要：
2019年冠状病毒病（COVID-19）疫苗接种的潜在不利影响引起了公众的关注。台湾疫苗伤害赔偿计划(VICP)的数据可以提供有价值的见解。本研究分析了台湾VICP的COVID-19疫苗补偿的初步应用数据，重点关注2021年3月至2022年6月期间接种疫苗的申请人。在2941起不良事件中，113例（3.8%）被认为与疫苗接种有因果关系，313（10.6%）是不确定的，2515（85.5％）无因果关系。近半数(47.6%)的申请人年龄超过60岁,76.6%有既往慢性病史。在426例疫苗相关或不确定的病例中，最常见的原因是血液病和血栓形成。报告了920例死亡病例，97.4%与疫苗接种无关。只有5例死亡被认为与COVID-19疫苗接种有关，均涉及腺病毒载体疫苗和血栓形成伴血小板减少综合征。总之,大多数补偿申请与疫苗接种没有因果关系.与其他国家相比,台湾VICP的申请数量相对较高。这些发现可能表明需要调整台湾计划中的赔偿申请要求。
